Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

CRYM protein suppresses overactive thyroid hormones ... researchers led by Lukas Kenner from the Department of Pathology at MedUni Vienna describes the molecular properties of the CRYM protein, its mode of action in various tissues and its role in obesity and diseases such as diabetes and, in particular, cancer. Thyroid hormones are essential regulators of... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-november-2022/protein-crym-daempft-uebertriebene-schilddruesenhormon-aktivitaet/medicine-science/
CRYM protein suppresses overactive thyroid hormones ... researchers led by Lukas Kenner from the Department of Pathology at MedUni Vienna describes the molecular properties of the CRYM protein, its mode of action in various tissues and its role in obesity and diseases such as diabetes and, in particular, cancer. Thyroid hormones are essential regulators of... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-november-2022/protein-crym-daempft-uebertriebene-schilddruesenhormon-aktivitaet/
News ...-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf Merkel und Gerda... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/eu-grant-fuer-krebsforschungs-trainingsnetzwerk-unter-mitwirkung-der-meduni-wien/
Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-eu-grant-fuer-krebsforschungs-trainingsnetzwerk-unter-mitwirkung-der-meduni-wien/
Detailsite | MedUni Vienna ... led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches. (Vienna, 15-06-2015) A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna and William Tse at James Graham Brown... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/breast-cancer-cells-form-metastases-the-responsible-gene-is-identified/
Detailsite | MedUni Vienna ... Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/cause-of-an-aggressive-form-of-childhood-cancer-identified/
Prostatakarzinom: Zwei Proteine als neue Indikatoren für aggressiveres Verhalten identifiziert ... eine Gruppe von Patienten mit aggressivem Verlauf und oft tödlichem Ausgang. In der gemeinsamen Arbeit eines Forschungsteams um Robert Wiebringhaus unter der Leitung von Lukas Kenner, Klinisches Institut für Pathologie der MedUni Wien und Abteilung für Labortierpathologie der Vetmeduni, Mitglied der... https://www.meduniwien.ac.at/web/ueber-uns/news/2021/news-im-dezember-2021/prostatakarzinom-zwei-proteine-als-neue-indikatoren-fuer-aggressiveres-verhalten-identifiziert/medizin-wissenschaft/
Prostatakarzinom: Zwei Proteine als neue Indikatoren für aggressiveres Verhalten identifiziert ... eine Gruppe von Patienten mit aggressivem Verlauf und oft tödlichem Ausgang. In der gemeinsamen Arbeit eines Forschungsteams um Robert Wiebringhaus unter der Leitung von Lukas Kenner, Klinisches Institut für Pathologie der MedUni Wien und Abteilung für Labortierpathologie der Vetmeduni, Mitglied der... https://www.meduniwien.ac.at/web/ueber-uns/news/2021/news-im-dezember-2021/prostatakarzinom-zwei-proteine-als-neue-indikatoren-fuer-aggressiveres-verhalten-identifiziert/
Prostate cancer: Protein identified to reduce tumour growth ... prostate is the second most common cause of cancer death in men. An international study led by Lukas Kenner (MedUni Vienna) and Sabine Lagger (Vetmeduni Vienna) has now identified a protein that could slow tumour growth. The results, which have just been published in the top journal "Molecular Cancer... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2024/default-6e9bbc87ad/prostate-cancer-protein-identified-to-reduce-tumour-growth/
Prostate cancer: Protein identified to reduce tumour growth ... prostate is the second most common cause of cancer death in men. An international study led by Lukas Kenner (MedUni Vienna) and Sabine Lagger (Vetmeduni Vienna) has now identified a protein that could slow tumour growth. The results, which have just been published in the top journal "Molecular Cancer... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2024/default-6e9bbc87ad/prostate-cancer-protein-identified-to-reduce-tumour-growth/medicine-science/